Alfred Hansel
Chief Executive Officer at oncgnostics GmbH
Profile
Alfred Hansel is the founder and Chief Executive Officer of oncgnostics GmbH, a company founded in 2012.
He holds a doctorate degree from the University of Freiburg and an undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Alfred Hansel active positions
| Companies | Position | Start |
|---|---|---|
oncgnostics GmbH
 oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Chief Executive Officer | 31/01/2012 |
Training of Alfred Hansel
| Friedrich-Alexander University of Erlangen-Nuremberg | Undergraduate Degree |
| University of Freiburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |
- Stock Market
- Insiders
- Alfred Hansel
